PliantTherapeuticsJPMorgan2025

© 2025 PLIANT THERAPEUTICSDeveloping Novel Treatments for Fibrotic DiseasesJ.P. MORGAN HEALTH CARE CONFERENCEJanuary 2025© 2025 PLIANT THERAPEUTICSDisclaimersThis presentation has been prepared by Pliant Therapeutics, Inc. ("we," "us," "our," "Pliant" or the “Company”). The informationset forth herein does not purport to be complete or to contain all of the information you may desire. Statements contained herein are made as of the date of this presentation unless stated otherwise, and this presentation shall not under any circumstances create an implication that the information contained herein is correct as of any time after such date or that information will be updated or revised to reflect information that subsequently becomes available or changes occurring after thedate hereof.This presentation includes forward-looking statements regarding Pliant’s proprietary drug candidates, the timing of the start and conclusion of ongoing or planned clinical trials, including the timing of, and